Detalhe da pesquisa
1.
Whole-genome sequencing reveals complex genomic features underlying anti-CD19 CAR T-cell treatment failures in lymphoma.
Blood
; 140(5): 491-503, 2022 08 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35476848
2.
Tumor interferon signaling and suppressive myeloid cells are associated with CAR T-cell failure in large B-cell lymphoma.
Blood
; 137(19): 2621-2633, 2021 05 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33512407
3.
Baseline Serum Inflammatory Proteins Predict Poor CAR T Outcomes in Diffuse Large B-cell Lymphoma.
Blood Cancer Discov
; 5(2): 106-113, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38194367
4.
Pneumococcal Conjugate Vaccine Does Not Induce Humoral Response When Administrated Within the Six Months After CD19 CAR T-Cell Therapy.
Transplant Cell Ther
; 29(4): 277.e1-277.e9, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35970303
5.
Survivin Dendritic Cell Vaccine Safely Induces Immune Responses and Is Associated with Durable Disease Control after Autologous Transplant in Patients with Myeloma.
Clin Cancer Res
; 29(22): 4575-4585, 2023 11 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37735756
6.
A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy.
Nat Med
; 29(4): 906-916, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36914893
7.
CAR-T manufactured from frozen PBMC yield efficient function with prolonged in vitro production.
Front Immunol
; 13: 1007042, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36225930
8.
Inhibition of Human Dendritic Cell ER Stress Response Reduces T Cell Alloreactivity Yet Spares Donor Anti-tumor Immunity.
Front Immunol
; 9: 2887, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30574153
9.
Survivin-specific CD4+ T cells are decreased in patients with survivin-positive myeloma.
J Immunother Cancer
; 3: 20, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25992291